Attenuation of Atherosclerosis by 3,4-Dihydroxy- Hydrocinnamic Acid in Rabbits by Partial Inhibition of ACAT

키워드

참고문헌 (28)

1. Hansson GK, "Inflammation and immunity in diseases of the arterial tree : players and layers", Circ Res, 116, pp.307~311 (2015)
2. Hansson GK, "The immune response in atherosclerosis : a double-edged sword", Nat Rev Immunol, 6, pp.508~519 (2006)
3. Hilgendorf I, "Monocyte fate in atherosclerosis", Arterioscler Thromb Vasc Biol, 35, pp.272~279 (2015)
4. Allahverdian S, "Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis", Circulation, 129, pp.1551~1559 (2014)
5. Rong JX, "Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading", Proc Natl Acad Sci U S A, 100, pp.13531~13536 (2003)
6. Vengrenyuk Y, "Cholesterol loading reprograms the microRNA-143", 145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype, 2015, pp.35, 535~546
7. Feil S, "Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis", Circ Res, 115, pp.662~667 (2014)
8. Rudel LL, "Acyl coenzyme A : cholesterol acyltransferase types 1 and 2 : structure and function in atherosclerosis", Curr Opin Lipidol, 12, pp.121~127 (2001)
9. Pedersen TR, "The success story of LDL cholesterol lowering", Circ Res, 19(118), pp.721~731 (2016)
10. Lee JS, "4-Hydroxycinnamate lowers plasma and hepatic lipids without changing antioxidant enzyme activities", Ann Nutr Metab, 47, pp.144~151 (2003)
11. Kusunoki J, "Acyl-CoA : cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice", Circulation, 103, pp.2604~2609 (2001)
12. Buhman KF, "Mammalian acyl-CoA : cholesterol acyltransferases", Biochim Biophys Acta, 1529, pp.142~154 (2000)
13. Fazio S, "Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages", J Clin Invest, 107, pp.163~171 (2001)
14. Wu C, "Chlorogenic acid protects against atherosclerosis in ApoE-", -mice and promotes cholesterol efflux from RAW264.7 macrophages, 2014, pp.4, e95452~
15. Noguchi N, "Phenolic antioxidants : a rationale for design and evaluation of novel antioxidant drug for atherosclerosis", Free Radic Biol Med, 28, pp.1538~1546 (2000)
16. Xu ZR, "Apple polyphenols decrease atherosclerosis and hepatic steatosis in ApoE-", - mice through the ROS, NF-B pathway, pp.Nutrients, 2015[DOI]
17. Nardini M, "Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives", Free Radical Biol Med, 19, pp.541~552 (1995)
18. Tanaka T, "Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids", Carcinogenesis, 14, pp.1321~1325 (1993)
19. Lee JS, "Lipid-lowering and antioxidative activities of 3, 4-di(OH)-cinnamate and 3, 4-di(OH)-hydrocinnamate in cholesterol-fed rats", Clin Chim Acta, 314, pp.221~229 (2001)
20. Erickson SK, "Rat liver ac yl-coenzyme A : cholesterol acyltransferase : its regulation in vivo and some of its properties in vitro", J Lipid Res, 21, pp.930~941 (1980)
21. Gillies PJ, "Regulation of acyl-CoA : cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas : role of a cholesterol substrate pool", Exp Mol Pathol, 44, pp.329~339 (1986)
22. Russell JC, "Small animal models of cardiovascular disease : tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis", Cardiovascular Pathology, 15, pp.318~330 (2006)
23. Ikenoya M, "A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels", Atherosclerosis, 191, pp.290~297 (2007)
24. Tauchi Y, "Inhibitory effect of acyl-CoA : cholesterol acyltransferase inhibitor-low density lipoprotein complex on experimental atherosclerosis", Biol Pharm Bull, 26, pp.73~78 (2003)
25. Nissen SE, "Effect of ACAT inhibition on the progression of coronary atherosclerosis", N Engl J Med, 354, pp.1253~1263 (2006)
26. Duewell P, "NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals", Nature, 464, pp.1357~1361 (2010)
27. Rong JX, "ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity", Arterioscler Thromb Vasc Biol, 33, pp.4~12 (2013)
28. Yoshinaka Y, "A selective ACAT-1 inhibitor, K-604, stimulates collagen production in cultured smooth muscle cells and alters plaque phenotype in apolipoprotein E-knockout mice", Atherosclerosis, 213, pp.85~91 (2010)

관련 논문AI추천